BioLine Rx Ltd (NAS:BLRX)
$ 0.268 -0.0125 (-4.46%) Market Cap: 26.49 Mil Enterprise Value: 28.28 Mil PE Ratio: 0 PB Ratio: 2.44 GF Score: 28/100

Q2 2024 BioLine RX Ltd Earnings Call Transcript

Aug 15, 2024 / 12:30PM GMT
Release Date Price: $0.6783 (-12.48%)
Operator

Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx second quarter 2024 financial results conference call. (Operator Instructions) Following management's formal presentation, instructions will be given for the question-and-answer session.

I would now like to hand the call over to John Lacey, Head of Investor Relations, and Corporate Communications. John, please go ahead.

John Lacey BioLine RX Ltd;Head of IR and Corporate Communications

Thank you, operator. Welcome, everyone. Thank you for joining us on our second quarter 2024 results conference call. Earlier today, we issued a press release, a copy of which is available in the Investor Relations section of our website. It was also filed as a 6-K.

I'd like to remind you that certain statements we make during the call will be forward-looking. Because such statements deal with future events, and are subject to many risks and uncertainties, actual results may differ materially from those in the forward-looking statements.

For a full discussion of these risks

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot